Efficient Payload Delivery by a Bispecific Antibody–Drug Conjugate Targeting HER2 and CD63

Bart E.C.G. de Goeij(Genmab (Netherlands)), Paul W.H.I. Parren(University of Southern Denmark)

Molecular Cancer Therapeutics

August 24, 2016

10.1158/1535-7163.mct-16-0364

Cited by 131

Related Papers

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors

|The Journal of Immunology|2010|1k

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

|mAbs|2015|502

Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy

|The Journal of Immunology|2004|149

Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action

|Cancer Research|2006|124